ClinicalTrials.gg
Drug

Brensocatib clinical trials

Also written INS1007 and AZD7986.

studies test it
17
open now
1
in phase 3
2
first study started
2016

How each study uses brensocatib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the brensocatib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Aug 2025 · BRINSUPRI · NDA 217673 (FDA, Drugs@FDA)
European Union
18 Nov 2025 · Brinsupri · EMEA/H/C/005820 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Brensocatib
12
Brensocatib 10 mg
2
Brensocatib 25 mg
2

Development codes

INS1007
14
AZD7986
3

Studies by the year they started

17 studies that test it; most in 2023 (4)

Studies that test brensocatib, by start year
YearStudies
20161
20171
20191
20202
20213
20222
20234
20242
20261

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
4
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 1

Insmed Incorporated (15) · University of Dundee (1) · AstraZeneca (1)

Often tested with

Tested in the same studies.

Midazolam (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test brensocatib.

Studies

Open first, then newest update. How each study uses brensocatib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Codes

What other systems call brensocatib · ClinicalTrials.gg INT000695

  • MeSH (NLM) C000619932brensocatibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 25CG88L0BBBRENSOCATIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q105334645brensocatibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171778BrensocatibOne source FDA
  • DrugBank DB15638One source Wikidata

Also registered as brensocatib monohydrate (UNII PFW1O9NG45).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.